UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathologic response as a strong predictor of survival irrespective of phenotype in early breast cancer

Annals of oncology, 2018-10, Vol.29, p.viii83-viii84

2018

Volltextzugriff (PDF)

Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

Breast (Edinburgh), 2021-04, Vol.56, p.S52-S53

2021

Volltextzugriff (PDF)

Abstract P3-08-24: Mutational characterization of HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-08-24

2019

Volltextzugriff (PDF)

Abstract P2-08-30: Vitamin D as a prognostic factor in triple negative early breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-08-30

2019

Volltextzugriff (PDF)

264PPathologic response as a strong predictor of survival irrespective of phenotype in early breast cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

266P - Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

Annals of oncology, 2019-10, Vol.30, p.v90-v90

2019

Volltextzugriff (PDF)

Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

Annals of oncology, 2019-10, Vol.30, p.v90

2019

Volltextzugriff (PDF)

266PPathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract P3-10-17: mRNA expression of HER2 by PCR as a strong predictor of pathologic response to neoadjuvant antiHER2 therapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-10-17

2019

Volltextzugriff (PDF)

278P - Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

Annals of oncology, 2019-10, Vol.30, p.v93-v93

2019

Volltextzugriff (PDF)

Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

Annals of oncology, 2019-10, Vol.30, p.v93

2019

Volltextzugriff (PDF)

278PCorrelation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

P087 - Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

Breast (Edinburgh), 2021-04, Vol.56, p.S52-S53

2021

Volltextzugriff (PDF)

P166 - Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S72-S72

2019

Volltextzugriff (PDF)

Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S72

2019

Volltextzugriff (PDF)

Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example

Journal of oncology pharmacy practice, 2024-04, Vol.30 (3), p.576-583

2024

Volltextzugriff (PDF)

High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2019-04, Vol.30, p.ii30-ii30

2019

Volltextzugriff (PDF)

TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor

Annals of oncology, 2019-04, Vol.30, p.ii5-ii5

2019

Volltextzugriff (PDF)

15PTTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

80PHigh blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

A brief dementia screener suitable for use by non-specialists in resource poor settings-the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia

International journal of geriatric psychiatry, 2011-09, Vol.26 (9), p.899-907

2011

Volltextzugriff (PDF)

P2.16-29 Lung Cancer in Lleida: An Epidemiologic Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S876-S877

2019

Volltextzugriff (PDF)

Comparison of Devices for Newborn Ventilation in the Delivery Room

The Journal of pediatrics, 2014-08, Vol.165 (2), p.234-239.e3

2014

Volltextzugriff (PDF)

P2664Long-term follow-up in a large cohort of survivors after out-of-hospital cardiac arrest: global mortality and comparison with age-specific mortality rate in the general population

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

EP1.01-92 Effectiveness of Second-Line Treatment with Nintedanib + Docetaxel (ND) in Patients with Metastatic Lung Adenocarcinoma

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S948-S948

2019

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Humans
(4)
Biological And Medical Sciences
(3)
Food Science & Technology
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Male
(3)
Minicontact Test
(3)
Saturation Temperature
(3)
Sherry Wines
(3)
Cold Treatment
(2)
Female
(2)
Fermented Food Industries
(2)
Food Industries
(2)
General Aspects
(2)
Potassium Bitartrate
(2)
Tartrate Stabilization
(2)
Wines And Vinegars
(2)
Aap
(1)
Adverse Events
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathologic response as a strong predictor of survival irrespective of phenotype in early breast cancer

Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

Abstract P3-08-24: Mutational characterization of HER2-positive breast cancer

Abstract P2-08-30: Vitamin D as a prognostic factor in triple negative early breast cancer

264PPathologic response as a strong predictor of survival irrespective of phenotype in early breast cancer

266P - Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

266PPathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer

Abstract P3-10-17: mRNA expression of HER2 by PCR as a strong predictor of pathologic response to neoadjuvant antiHER2 therapy

278P - Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

278PCorrelation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival

P087 - Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

P166 - Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example

High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)

TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor

15PTTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor

80PHigh blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)

A brief dementia screener suitable for use by non-specialists in resource poor settings-the cross-cultural derivation and validation of the brief Community Screening Instrument for Dementia

P2.16-29 Lung Cancer in Lleida: An Epidemiologic Study

Comparison of Devices for Newborn Ventilation in the Delivery Room

P2664Long-term follow-up in a large cohort of survivors after out-of-hospital cardiac arrest: global mortality and comparison with age-specific mortality rate in the general population

EP1.01-92 Effectiveness of Second-Line Treatment with Nintedanib + Docetaxel (ND) in Patients with Metastatic Lung Adenocarcinoma

Suchergebnisse filtern